Kerry Wentworth
CIK 1369453 · CHIEF REGULATORY OFFICER · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$361.5K
Companies
4
Total Filings
75
Lifetime Open-Market Net
-$1.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVB | CHIEF REGULATORY OFFICER | 53,000 | $6.46 | $342.1K | -$1.47M | 4 | 2026-06-24 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | CHIEF REGULATORY OFFICER | 50,000 | $0.01 | $255 | $89.7K | 6 | 2025-06-18 |
| FLXN | Chief Regulatory Officer | 0 | $24.64 | $0 | -$109.1K | 17 | 2021-11-19 |
| AGEN | VP, Clinical, Reg & Qual | 2,870 | $6.75 | $19.4K | -$90.9K | 45 | 2014-02-28 |
Recent Filings · Page 3 of 8
75 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-03 | FLXN | Grant (A) | +31,000 | $0 | EDGAR |
| 2020-01-07 | FLXN | Sell (S) | −3,724 | $0 | EDGAR |
| 2019-10-08 | FLXN | Mixed | +2,398 | -$14.0K | EDGAR |
| 2019-06-24 | FLXN | Grant (A) | +389 | $3.8K | EDGAR |
| 2019-03-05 | FLXN | Mixed | +2,398 | -$18.6K | EDGAR |
| 2019-03-05 | FLXN | Grant (A) | +36,000 | $0 | EDGAR |
| 2019-01-04 | FLXN | Sell (S) | −622 | -$7.7K | EDGAR |
| 2018-10-09 | FLXN | Tax (F) | −1,002 | -$18.6K | EDGAR |
| 2018-06-22 | FLXN | Other (J) | +171 | $3.6K | EDGAR |
| 2018-02-02 | FLXN | Grant (A) | +8,333 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.